BioGraphene Presented at the 10th Annual Neurodegenerative Drug Development Summit

2022
Written By BioGraphene
 

BioGraphene Inc. participated in the 10th Annual Neurodegenerative Drug Development Summit (March 28~30, Boston/USA). The three day event brought together thought leaders, industry professionals, and academic experts to share and highlight the most recent advancements in the science of neurodegenerative diseases.

Dr. Je Min Yoo, Chief Technology Officer, was invited to present about “The New Target Journey: How to Progress from Target Identification & Illustrate Meaningful Effect in Pre-Clinical Models”.

BioGraphene
Previous

BioGraphene Appoints Dr. Daehee Kang as Medical Advisor
Next

BioGraphene Signs Patent License Agreement with Seoul National University and Johns Hopkins University